A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Vanderbilt University